MACITENTAN
Generic: MACITENTAN
Novugen Pharma (USA) LLCManufacturer
ORALRoute
MACITENTANActive Substance
2025-12-03Original Approval
MACITENTAN is FDA application ANDA211026, sponsored by LEPU PHARM. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DYSPNOEA
1,058 reports
2
DEATH
779 reports
3
HEADACHE
610 reports
4
PNEUMONIA
537 reports
5
DIARRHOEA
492 reports
6
NAUSEA
447 reports
7
PULMONARY ARTERIAL HYPERTENSION
416 reports
8
FATIGUE
415 reports
9
FLUID RETENTION
376 reports
10
HYPOTENSION
367 reports